Ординатура / Офтальмология / Английские материалы / Handbook of Pediatric Eye and Systemic Disease_Wright, Spiegel, Thompson_2006
.pdf
CHAPTER 5: CONNECTIVE TISSUE, SKIN, AND BONE DISORDERS |
283 |
185.Mir S, Wheatley HM, Maumenee Hussels IE, Whittum-Hudson J, Traboulsi EI. A comparative study of the fibrillin microfibrillar system in the lens capsule of normal and Marfan syndrome patients. Investig Ophthalmol Vis Sci 1998;39:84–93.
186.Mirhosseini SL, Holmes LB, Walton DS. Syndrome of pigmentary retinal degeneration, cataract, microcephaly, and severe mental retardation. J Med Genet 1972;9:193–196.
187.Morgan JD. Incontinentia pigmenti (Bloch–Sulzberger syndrome) A report of four additional cases. Am J Dis Child 1971;122:294– 300.
188.Morse RP, Rockenmacher S, Pyeritz RE, et al. Diagnosis and management of infantile Marfan syndrome. Pediatrics 1990;86: 888–894.
189.Moyer DB, et al. Cockayne syndrome with early onset of manifestations. Am J Med Genet 1982;13:225–230.
190.Mudd SH, et al. Disorders of transulfuration. In: Scriver C, et al (eds) The metabolic basis of inherited disease. New York: McGrawHill, 1989:693–734.
191.Mueller RF, Crowle PM, Jones RAK, Davison BCC. X-linked dominant chondrodysplasia punctata: a case report and family studies. Am J Med Genet 1985;20:137–144.
192.Murdoch JL, Walker BA, Halpern BL, et al. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 1972;286: 804–808.
193.Neldner KH. Pseudoxanthoma elasticum. Clin Dermatol 1988;6(1): 83–92.
194.Newsome DA, Kraemer KH, Robbins JH. Repair of DNA in xeroderma pigmentosum conjunctiva. Arch Ophthalmol 1975;93:660– 662.
195.Nik NA, Glew WB, Zimmerman LE. Malignant melanoma of the choroid in the nevus of Ota of a black patient. Arch Ophthalmol 1983;100:1641–1643.
196.Norio R, Raitta C. Are the Mirhosseini–Holmes–Walton syndrome and the Cohen syndrome identical? Am J Med Genet 1986;25:397– 398.
197.Norio R, Raitta C, Lindahl E. Further delineation of the Cohen syndrome; report on chorioretinal dystrophy, leukopenia and consanguinity. Clin Genet 1984;25:1–14.
198.North C, Patton MA, Baraitser M, Winter RM. The clinical features of the Cohen syndrome: further case reports. J Med Genet 1985;22:131–134.
199.O’Donnell FE Jr, King RA, Green WR, Wilkope J Jr. Autosomal recessively inherited ocular albinism: a new form of ocular albinism affecting females as severely as males. Arch Ophthalmol 1978;96:1621–1625.
200.O’Donnell FE Jr, Hambrick GW Jr, Green WR, Iliff WJ, Stone DL: X-linked ocular albinism: an oculocutaneous macromelanosomal disorder. Arch Ophthalmol 1976;94:1883–1892.
284HANDBOOK OF PEDIATRIC EYE AND SYSTEMIC DISEASE
201.O’Donnell FE Jr, Green WR, Fleischman JA, Hambrick GW. X- linked ocular albinism in blacks. Ocular albinism cum pigmento. Arch Ophthalmol 1978;96:1189–1192.
202.Ohdo S, et al. Association of ectodermal dysplasia, ectrodactyly, and macular dystrophy: the EEM syndrome. J Med Genet 1983;20:52–57.
203.Oorthuys JWE, Loewer-Sieger DH, Schutgens RBH, Wanders RJA, Heymans HSA, Bleeker-Wagemakers EM. Peroxisomal dysfunction in chondrodysplasia punctata, rhizomelic type. Ophthalmic Paediatr Genet 1987;8:183–185.
204.Opitz JM, France TD, Hermann J, Spranger JW. The Stickler syndrome. N Engl J Med 1972;286:546–547.
205.Ormerod AD, White MI, McKay E, Johnston AW. Incontinentia pigmenti in a boy with Klinefelter’s syndrome. J Med Genet 1987; 24:439–441.
206.Ota M. Nevus fusco-caeruleus ophthalmomaxillaris. Tokyo Med J 1939;63:1243–1245.
207.Otsuka F, Robbins JG. The Cockayne sydnrome. An inherited multisystem disorder with cutaneous photosensitivity and defective repair of DNA. Am J Dermatopathol 1985;7:387.
208.Patton MA, et al. Early onset Cockayne’s syndrome: case reports with neuropathological and fibroblast studies. J Med Genet 1989; 26:154–159.
209.Pearce WG. Ocular and genetic features of Cockayne’s syndrome. Can J Ophthalmol 1972;7:435.
210.Pearce WG, Sauger R, Race RR. Ocular albinism and Xg. Lancet 1968;1:1282–1283.
211.Pedersen U. Bramsen T. Central corneal thickness in osteogenesis imperfecta and otosclerosis. J Otorhinolaryngol Relat Spec 1984;46: 38–41.
212.Percival SPB. Angioid streaks and elastorrhexis. Br J Ophthalmol 1968;52:297–309.
213.Pope FM. Two types of autosomal recessive pseudoxanthoma elasticum. Arch Dermatol 1974;110:209–212.
214.Pope FM. Autosomal dominant pseudoxanthoma elasticum. J Med Genet 1974;11:152–157.
215.Pope FM. Historical evidence for the genetic heterogeneity of pseudoxanthoma elasticum. Br J Dermatol 1975;92:493–509.
216.Preus M, et al. Waardenburg syndrome: penetrance of major signs. Am J Med Genet 1983;15:383–388.
217.Pries C, Mittleman D, Miller M, et al. The EEC syndrome. Am J Dis Child 1974;127:840.
218.Pyeritz RE. Marfan syndrome: guidelines for recognizing an elusive disorder. J Musculoskel Med 1990;Dec:21–35.
219.Pyeritz RE, Fishman EK, Bernhardt BA, et al. Dural ectasia is a common feature of the Marfan syndrome. Am J Hum Genet 1988; 43:726–732.
220.Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med 1979;300:772–777.
CHAPTER 5: CONNECTIVE TISSUE, SKIN, AND BONE DISORDERS |
285 |
221.Rahi J, Hungerford J. Early diagnosis of the retinopathy of incontinentia pigmenti: successful treatment by cryotherapy. Br J Ophthalmol 1990;74:377–379.
222.Rainbow AJ, Howes MA. A deficiency in the repair of UV and gamma-ray damaged DNA in fibroblasts from Cockayne’s syndrome. Mutat Res 1982;93:235.
223.Ramsey MS, Fine BS, Shields JA, et al. The Marfan syndrome. Am J Ophthalmol 1973;76:102–116.
224.Ramsey MS, Dickson DH. Lens fringe in homocystinuria. Br J Ophthalmol 1975;59:338–342.
225.Ramsey MS, Yanoff M, Fine BS. The ocular histopathology of homocystinuria. A light and electron microscopic study. Am J Ophthalmol 1972;74:377–385.
226.Rennert OM. The Marchesani syndrome. A brief review. Am J Dis Child 1969;117:703–705.
227.Resnick K, Zuckerman J, Cotlier E. Cohen syndrome with bull’s eye macular lesion. Ophthalmic Paediatr Genet 1986;7:1–8.
228.Riedner ED, Levin LS, Holliday MJ. Hearing patterns in dominant osteogenesis imperfecta. Arch Otolaryngol 1980;106:737–740.
229.Riggs W Jr, Seibert J. Cockayne’s syndrome. Roentgen findings. Am J Roentgenol 1972;116:623.
230.Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad USA 2000;97:6001–6006.
231.Robbins JH, Kraemer KH, Lutzner MA, et al. Xeroderma pigmentosum: an inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974; 80:221–248.
232.Roberts WM, Jenkins JJ, Moorhead EL, Douglass EC. Incontinentia pigmenti, a chromosomal instability syndrome, is associated with childhood malignancy. Cancer (Phila) 1988;62:2370.
233.Rodini ESO, Richieri-Costa A. EEC syndrome: report of 20 new patients, clinical and genetic considerations. Am J Med Genet 1990;37:42–53.
234.Rollnick BR, Hoo JJ. Genitourinary anomalies are a component of the ectodermal dysplasia, ectrodactyly, cleft lip/palate (EEC) syndrome. Am J Med Genet 1988;29:131–136.
235.Roper SS, Spraker MK. Cutaneous histiocytosis syndromes. Paediatr Dermatol 1985;3:19–30.
236.Rosen E. Fundus in pseudoxanthoma elasticum. Am J Ophthalmol 1968;66:236–244.
237.Rovin S, Dachi SF, Borenstein DB, Cotter WB. Mandibulofacial dysostosis. A familial study of five generations. J Pediatr 1964;65: 215–221.
238.Royce PM, Steimann B, Vogel A, Steinhorst U, Kohlschuetter A. Brittle cornea syndrome: an heritable connective tissue disorder distinct from Ehlers–Danlos syndrome type VI and fragilis oculi,
286 |
HANDBOOK OF PEDIATRIC EYE AND SYSTEMIC DISEASE |
with spontaneous perforations of the eye, blue sclerae, red hair, and normal collagen lysyl hydroxylation. Eur J Pediatr 1990;149:465– 469.
239.Ruben JB, Morris RJ, Judisch GF. Chorioretinal degeneration in infantile malignant osteopetrosis. Am J Ophthalmol 1990;110:1–5.
240.Rudiger RA, Haase W, Passarge E. Association of ectrodactyly, ectodermal dysplasia, and cleft lip-palate. Am J Dis Child 1970;120: 160–163.
241.Russell LJ, DiGiovanna JJ, Hashem N, Compton JG, Bale SJ. Linkage of autosomal recessive lamellar ichthyosis to chromosome 14q. Am J Hum Genet 1994;55:1146–1152.
242.Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 1986; 103:2499–2509.
243.Sanders RC, Broers CJM, Pyeritz RE. Sonography of the Marfan syndrome in utero. (Abstract). Am J Med Genet 1989;32:239.
244.Sanders TE. Intraocular juvenile xanthogranuloma. Trans Am Ophthalmol Soc 1960;58:59–74.
245.Secretan M, Zografos L, Guggisberg D, Piguet B. Chorioretinal vascular abnormalities associated with angioid streaks and pseudoxanthoma elasticum.Arch Ophthalmol 1998;116:1333–1336.
246.Seery CM, Pruett RC, Liberfarb RM, Choen BZ. Distinctive cataract in the Stickler syndrome. Am J Ophthalmol 1990;110:143–148.
247.Sefiani A, Abel L, Hellert ZS, et al. The gene for incontinentia piigmenti is assigned to Xq28. Genomics 1989;4:427–429.
248.Sefiani A, M’rad R, Simard L, et al. Linkage relationship between incontinentia pigmenti (IP2) and nine terminal X long arm markers. Hum Genet 1991;86:297–299.
249.Seguin LR, et al. Ultraviolet light-induced chromosomal aberrations in culture cells from Cockayne syndrome and complementation group C xeroderma pigmentosum patients: lack of correlation with cancer susceptibility. Am J Hum Genet 1988;42:468.
250.Shapiro LJ, Weiss R, Buxmann MM, et al. Enzymatic basis of typical x-linked ichthyosis. Lancet 1978;2:756–757.
251.Sheffield LJ, et al. Chondrodysplasia punctata: 23 cases of a mild and relatively common variety. J Pediatr 1976;89:916–923.
252.Sheffield LJ, Osborn AH, Hutchison WM, et al. Segregation of mutations in arylsulphatase E and correlation with the clinical presentation of chondrodysplasia punctata. J Med Genet 1998;35:1004–1008.
253.Shemen LJ, et al. Cockayne syndrome, an audiologic and temporal bone analysis. Am J Otolaryngol 1984;5:300.
254.Sherer DW, Bercovitch L, Lebwohl M. Pseudoxanthoma elasticum: significance of limited phenotypic expression in parents of affected offspring. J Am Acad Dermatol 2001;44:534.
255.Shimizu K. Mottled fundus in association with PXE. Jpn J Ophthalmol 1961;5:1–13.
256.Silengo MC, Luzzatti L, Silverman FN. Clinical and genetic aspects of Conradi–Hunermann disease. J Pediatr 1980;97:911–917.
CHAPTER 5: CONNECTIVE TISSUE, SKIN, AND BONE DISORDERS |
287 |
257.Silengo MC, et al. Distinctive skeletal dysplasia in Cockayne syndrome. Pediatr Radiol 1986;16:264.
258.Sillence DO, Rimoin DL. Classification of osteogenesis imperfecta. Lancet 1978;1:1042.
259.Sillence DO, Barlow KK, Garber AP, Hall JG, Rimoin DL. Osteogenesis imperfecta type II: delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet 1984;17:407– 423.
260.Sisk HE, Zahka KG, Pyeritz RE. The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. Am J Cardiol 1983;52:353–358.
261.Sjogren T, Larsson T. A clinical and genetic study of oligophrenia in combination with congenital ichthyosis and spastic disorders. Acta Psychiatr Neurol Scand 1957;32(suppl 113):1–112.
262.Skinner BA, Greist MC, Norins AL. The keratitis, ichthyosis, and deafness (KID) syndrome. Arch Dermatol 1981;117:285–289.
263.Sly WS, Whyte MP, Sundaram V, et al. Carbonic anhydrase II deficiency in 12 fmilies with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 1985;313:139.
264.Snead MP, Yates JR. Clinical and molecular genetics of Stickler syndrome. J Med Genet 1999;36:353–359.
265.Sonada T, Hashimoto H, Enjoji M. Juvenile xanthogranuloma. Cancer (Phila) 1985;56:2280–2286.
266.Spallone A. Incontinentia pigmenti (Bloch–Sulzberger syndrome). Seven case reports from one family. Br J Ophthalmol 1987;71:629– 634.
267.Spallone A. Stickler’s syndrome: a study of 12 families. Br J Ophthalmol 1987;71:504–509.
268.Spranger JW, Opitz JM, Bidder U. Heterogeneity of chrondrodysplasia punctata. Humangenetik 1971;11:190–212.
269.Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophthalmia: report of two cases in children. Am J Dis Child 1922;24:526.
270.Stickler GB, Belu PG, Farrell FG, et al. Hereditary progressive arthroophthalmopathy. Mayo Clin Proc 1965;40:433–455.
271.Stickler GB, Pugh DG. Hereditary progressive arthroophthalmopathy: additional observations on vertebral abnormalities, a hearing defect, and a report of a similar case. Mayo Clin Proc 1967;42:495–500.
272.Struk B, Neldner KH, Rao VS, St Jean P, Lindpainter K. Mapping of both autosomal recessive and dominant variants of pseudoxanthoma elasticum to chromosome 16p13.1. Hum Mol Genet 1997;6: 1823–1828.
273.Sugar HS. Oculodentodigital dysplasia syndrome with angleclosure glaucoma. Am J Ophthalmol 1978;86:36.
274.Sugar HS, Thompson JP, Davis JD. The oculo-dento-digital dysplasia syndrome. Am J Ophthalmol 1966;61:1448.
288HANDBOOK OF PEDIATRIC EYE AND SYSTEMIC DISEASE
275.Sulzberger MB. Uber eine bisher nicht beschriebene congenitale Pigmentanomalie (incontinentia pigmenti). Arch Dermatol Syphilol (Berl) 1928;154:535–542.
276.Summers CG, Creel D, Townsend D, King RA. Variable expression of vision in sibs with albinism. Am J Hum Genet 1991;40:327– 331.
277.Tahvanainen E, Norio R, Karila E, et al. Cohen syndrome gene assigned to the long arm of chromosome 8 by linkage analysis. Nat Genet 1994;7:201–204.
278.Tanaka K, Kawai K, Kumahara Y, Ikenaga M, Okada Y. Genetic complementation groups in Cockayne syndrome. Somatic Cell Genet 1981;7:445.
279.Teekhasaenee C, Ritch R, Rutnin U, Leelawongs N. Glaucoma in oculodermal melanocytosis. Ophthalmology 1990;97:562–570.
280.Temple IK. Stickler syndrome. J Med Genet 1989;26:119–126.
281.The International Incontinentia Pigmenti Consortium. Genomic rearrangement in NEMO impairs NF-kappa-B activation and is a cause of incontinentia pigmenti. Nature (Lond) 2000;405:466– 472.
282.Traboulsi EI, Faris BM, Der Kaloustian VM. Persistent hyperplastic primary vitreous and recessive oculo-dento-osseous dysplasia.
Am J Med Genet 1986;24:95.
282a. Traboulsi EI, Izin A, Massicotte SJ, et al. Posterior scleral choristoma in the organoid nevus syndrome (linear sebaceous of Jadassohn). Ophthalmology 1999;10:2126–2130.
283.Traboulsi EI, Maumenee IH. Bilateral melanosis of the iris. Am J Ophthalmol 1987;103:115–116.
284.Traboulsi EI, Maumenee IH, Kolsky M, Wilson D, Weleber R. Ophthalmologic findings in chondrodysplasia punctata (Abstract). Ophthalmology 1989.
285.Traboulsi EI, Parks MM. Glaucoma in oculo-dento-osseous dysplasia. Am J Ophthalmol 1990;109:310–313.
286.Traboulsi EI, DeBecker I, Maumenee IH. Ocular findings in Cockayne syndrome. Am J Ophthalmol 1992;114:579–583.
287.Traboulsi EI, Whittum-Hudson J, Mir S, Maumenee IH. Microfibril abnormalities of the lens capsule in patients with Marfan syndrome and ectopia lentis. Ophthalmic Genet 2000;21:9–15.
288.Tse K, Temple IK, Baraitser M. Dilemmas in counseling: the EEC syndrome. J Med Genet 1990;27:752–757.
289.Tsipouras P, Del Mastro R, Sarfarazi M, et al. Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. N Engl J Med 1992;326:905–909.
290.Tucker K, Lipson A. Choanal atresia as a feature of ectrodactylyectodermal dysplasia-clefting (EEC) syndrome: a further case [Letter]. J Med Genet 1990;27:213.
291.Uitto AU, et al. Focal dermal hypoplasia: abnormal characteristics of skin fibroblasts in culture. J Invest Dermatol 1980;75:170–175.
CHAPTER 5: CONNECTIVE TISSUE, SKIN, AND BONE DISORDERS |
289 |
292.van Dorp DB, Delleman JW, Loewer-Sieger DH. Oculocutaneous albinism and anterior chamber cleavage malformations. Not a coincidence. Clin Genet 1984;26:440–444.
293.Viljoen DL, Pope FM, Beighton P. Heterogeneity of pseudoxanthoma elasticum: delineation of a new form? Clin Genet 1987;32:100–105.
294.Vintiner GM, Temple IK, Middleton-Price HR, Baraitser M, Malcolm S. Genetic and clinical hetrogeneity of Stickler syndrome. Am J Med Genet 1991;41:44–48.
295.Vogel A, Holbrook A, Steinmann B, Gitzelmann R, Byers PH. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers–Danlos syndrome. Lab Investig 1979;40:201–206.
296.Wachtel JG. The ocular pathology of Marfan’s syndrome. Arch Ophthalmol 1966;76:512–522.
297.Wagner H. Ein bisher unbekanntes Erbleiden des Auges (degeneratio hyaloideo-retinalis hereditaria), beobachtet im Kanton Zurich. Klin Monatsbl Augenheilkd 1938;100:840–857.
298.Wanders RJA, Saelman D, Heymans HSA, et al. Genetic relation between the Zellweger syndrome, infantile refsum disease, and rhizomelic chondrodysplasia punctata. N Engl J Med 1986;314: 787–788.
299.Warburg M, Pedersen SA, Horlyk H. The Cohen syndrome. Retinal lesions and granulocytopenia. Ophthalmic Paediatr Genet 1990;11: 7–13.
300.Watzke RC, Stevens ST, Carney RG. Retinal vascular changes of incontinentia pigmenti. Arch Ophthalmol 1976;94:743–746.
301.Weill G. Ectopie des crystallins et malformations generales. Annu Oculist 1932;169:21–44.
302.Weintraub DM, Baum JL, Pashayan HM. A family with oculodentodigital dysplasia. Cleft Palate J 1975;12:323.
303.Wells RS, Kerr CB. Genetic classification of ichthyosis. Arch Dermatol 1965;92:1–6.
304.Wells RS, Kerr CB. Clinical features of autosomal dominant and sex-linked ichthyosis in an English population. Br Med J 1966;1: 947–950.
305.Wenstrup RJ, Willing MC, Starman BJ, Byers PH. Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta. Am J Hum Genet 1990;46:975–982.
306.Wheatley HM, Traboulsi EI, Flowers BE, Maumenee IH, WhittumHudson J. Immunohistochemical localization of fibrillin in human ocular tissues. Arch Ophthalmol 1995;113:103–109.
307.White JG, Clawson CC. The Chediak–Higashi syndrome: the nature of the giant neutrophil granules and their interactions with cytoplasm and foreign particulates. Am J Pathol 1980;98:151.
308.Wilkin DJ, Artz AS, South S, et al. Small deletions in the type II collagen triple helix produce Kniest dysplasia. Am J Med Genet 1999;85:105–112.
309.Willi M, Kut L, Cotlier E. Pupillary block glaucoma in the Marchesami syndrome. Arch Ophthalmol 1973;90:504–508.
290HANDBOOK OF PEDIATRIC EYE AND SYSTEMIC DISEASE
310.Winterpracht A, Hilbert M, Schwarze U, Mundlos S, Spranger J, Zabel RU. Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect. Nat Genet 1993;3:323–326.
311.Wright KM, Chrousos GA. Weill–Marchesani syndrome with bilateral angle-closure glaucoma. J Pediatr Ophthalmol Strabismus 1985;22:129–132.
312.Zimmerman LE. Ocular lesions of juvenile xanthogranuloma. Am J Ophthalmol 1965;60:1011–1035.
313.Zlotogora J, BenEzra D, Cohen T, Cohen E. Syndrome of brittle cornea, blue sclera, and joint hyperextensibility. Am J Med Genet 1990;36:269–272.
6
Neurocutaneous Syndromes
Maria A. Musarella
The neurocutaneous disorders are a group of clinically and genetically heterogeneous diseases that are characterized mainly by harmatomas and tumor growth, involving tissues derived by the embryonic germ layer. Older literature has called these disorders “phakomatoses” (mother-spot). The modern nomenclature and traditional eponyms of these entities are given in Table 6-1. Each of the neurocutaneous diseases is rec-
ognized as a distinct clinical disorder.
This chapter covers the ophthalmic aspects of these syndromes, as well as the numerous and varied multisystemic manifestations. Although Proteus syndrome and multiple endocrine neoplasia (MEN) 2B are considered separate from the neurocutaneous diseases, they are covered here because of the clinical resemblance to classic phakomatoses.
NEUROFIBROMATOSIS 1
Historical Perspective
Dr. Robert William Smith first described neurofibromatosis 1 (NF1) in 1849 in his treatise on Pathology Diagnosis and Treatment of Neuroma.100 However, this work received little attention. Neurofibromatosis is most closely linked with the German pathologist, von Recklinghausen, who described the main features of this entity in his classic paper of 1882.111
Etiology
About 50% of cases of NF1 result from new mutations. The NF1 gene has been mapped to 17q11.2 and positionally cloned. The
291
292 |
HANDBOOK OF PEDIATRIC EYE AND SYSTEMIC DISEASE |
|
|
||
TABLE 6-1. Neurocutaneous Syndromes. |
||
Modern nomenclature |
Eponyms |
|
Neurofibromatosis 1 |
von Recklinghausen disease |
|
|
|
Peripheral neurofibromatosis |
Neurofibromatosis 2 |
Central neurofibromatosis |
|
Tuberous sclerosis |
Bourneville disease |
|
von Hippel–Lindau Disease |
|
|
Ataxia telangiectasia |
Louis–Bar syndrome |
|
Sturge–Weber |
|
Encephalotrigeminal angiomatosis |
Klippel–Trenaunay |
Angiosteohypertrophy |
|
Wyburn-Mason syndrome |
Racemose angiomatosis |
|
Multiple endocrine neoplasia 2B |
Mucosal neuroma syndrome |
|
|
|
(Wagenmann–Froboese) |
Proteus syndrome |
|
|
|
|
|
NF1 gene is one of the largest genes in which mutations lead to a disease in humans. It is approximately 350 kb in size, consists of 60 exons, and encodes for 11 to 13 transcripts with an open reading frame coding for 2818 amino acids.14 In 1990, the NF1 gene and its protein product, neurofibromin, were identified. The gene product is as a tumor suppressor protein.27,42,108 The protein encoded by NF1 has structural and functional similarity to a family of GTPase-activating proteins (GAPs) that down-reg- ulate a cellular proto-oncogene, p21-ras. ras has been implicated in the control of cell growth and differentiation, and the capability of neurofibromin to down-regulate p21-ras suggests that the loss of neurofibromin may lead to uncontrolled cell growth and tumor formation.4,40,73
Incidence
NF1 is estimated to affect 1 in 3500 individuals.46
Ophthalmologic FEatures
Ophthalmologic features of NF1 are listed in Table 6-2. The most common uveal finding in NF1 is the Lisch nodule, which is a melanocytic harmatoma of the iris.63 These harmatomas appear as elevated, smooth, clear to yellowish or brown, gelatinous, dome-shaped lesions (Fig. 6-1). Lisch nodules are usually multiple, bilateral, and discrete, measuring up to 2 mm in diameter. Lubs and associates examined the prevalence of Lisch nodules in children. Lisch nodules were found in only 5% of NF1
